Niagen Bioscience Inc logo

Niagen Bioscience Inc

NAGE | NASDAQ
Chart Builder DCF Calculator
$3.04
+$0.05 (+1.67%)
At close: Sep 21, 2026, 4:00 PM ET
$3.09
+$0.05 (+1.63%)
Pre-market: Sep 22, 2026, 7:04 AM ET

Market Data

Market Cap
$242.12M
Enterprise Value
$177.71M
Beta
2.09
Average Volume
770.4K
Shares Outstanding (Diluted)
82.5M
Shares Change YoY
-4.33%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US1710774076

Price Performance

Price Change 1M
-5.0%
Price Change 3M
-10.1%
Price Change 6M
-32.7%
Price Change YTD
-51.4%
Price Change 1Y
-70.3%
Price Change 3Y
121.9%
Price Change 5Y
-52.9%
1M CAGR (ann.)
-2.6%
1Y CAGR (ann.)
-70.0%
5Y CAGR (ann.)
-16.1%
All-Time CAGR
-7.1%

Valuation

PE Ratio
16.00
Forward PE
17.66
PEG Ratio
-0.90
Forward PEG
2.10
PS Ratio
1.88
Forward PS
1.60
PB Ratio
2.93
P/FCF Ratio
42.67
P/Adj. FCF Ratio
-190.79
P/OCF Ratio
43.43
EV/Sales
1.38
EV/EBIT
10.67
EV/EBITDA
9.62
EV/FCF
31.32
Earnings Yield
6.3%
FCF Yield
2.3%
Adj. FCF Yield
-0.5%

Financial Health

Net Cash
$66.74M
Total Debt
$2.33M
Cash & Short-Term Investments
$66.74M
Total Assets
$106.59M
Current Ratio
6.50
Quick Ratio
5.13
Debt / Equity Ratio
0.03
Debt / EBITDA
0.13
Debt / FCF
0.41
OCF / Debt
2.55
Interest Coverage
0.00
Altman Z-Score
6.63
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
64.2%
Operating Profit Margin
6.7%
EBITDA Margin
14.3%
Net Profit Margin
12.4%
FCF Margin
4.4%
Adj. FCF Margin
-1.0%
SBC / Revenue
5.4%
SBC Impact (per share)
-122.4%

Returns

Return on Assets
15.0%
Return on Equity
20.5%
Return on Invested Capital
8.8%
Return on Capital Employed
9.4%
Return on Tangible Assets
15.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
16.8%
Revenue CAGR 5Y
15.8%
Revenue CAGR 10Y
17.0%
EPS CAGR 3Y
81.7%
EPS CAGR 5Y
644.7%
EPS CAGR 10Y
33.6%
FCF CAGR 3Y
50.1%
FCF CAGR 5Y
522.2%
FCF CAGR 10Y
45.5%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
5
EPS Growth Next 3Y
19.4%
Revenue Growth Next 3Y
17.6%
Earnings Date
Nov 2, 2026
EPS Estimate (next Q)
$0.01
EPS Growth Est (next Q)
-80.0%
Revenue Est (next Q)
$34.45M
Revenue Growth Est (next Q)
1.4%

Fair Value Estimates

Graham Number
$2.11
Graham Upside
-30.6%
Lynch Fair Value
$4.75
Lynch Upside
56.3%
Price Target
$10.33
Price Target Upside
239.8%

Cash Flow

Operating Cash Flow
$5.95M
Free Cash Flow
$5.67M
Adj. Free Cash Flow
$-1.27M
FCF Per Share
$0.07
OCF Per Share
$0.07
OCF/S Ratio
4.6%

Income Statement

Revenue
$129.08M
Gross Profit
$82.92M
Operating Income
$8.62M
EBITDA
$18.48M
Net Income
$15.99M
EPS (Diluted)
$0.19
Revenue / Employee
$1.1M
Profit / Employee
$136.68K
Employees
117

© 2026 bestshares.com. All rights reserved.